Cargando…

Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review

This review addressed drug interactions precipitated by fruit juices other than grapefruit juice based on randomized controlled trials (RCTs). Literature was identified by searching PubMed, Cochrane Library, Scopus and Web of Science till December 30 2017. Among 46 finally included RCTs, six RCTs si...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meng, Zhou, Shu-yi, Fabriaga, Erlinda, Zhang, Pian-hong, Zhou, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326888/
https://www.ncbi.nlm.nih.gov/pubmed/29703387
http://dx.doi.org/10.1016/j.jfda.2018.01.009
_version_ 1784757390420213760
author Chen, Meng
Zhou, Shu-yi
Fabriaga, Erlinda
Zhang, Pian-hong
Zhou, Quan
author_facet Chen, Meng
Zhou, Shu-yi
Fabriaga, Erlinda
Zhang, Pian-hong
Zhou, Quan
author_sort Chen, Meng
collection PubMed
description This review addressed drug interactions precipitated by fruit juices other than grapefruit juice based on randomized controlled trials (RCTs). Literature was identified by searching PubMed, Cochrane Library, Scopus and Web of Science till December 30 2017. Among 46 finally included RCTs, six RCTs simply addressed pharmacodynamic interactions and 33 RCTs studied pharmacokinetic interactions, whereas seven RCTs investigated both pharmacokinetic and pharmacodynamic interactions. Twenty-two juice-drug combinations showed potential clinical relevance. The beneficial combinations included orange juice-ferrous fumarate, lemon juice-(99m)Tc-tetrofosmin, pomegranate juice-intravenous iron during hemodialysis, cranberry juice-triple therapy medications for H. pylori, blueberry juice-etanercept, lime juice-antimalarials, and wheat grass juice-chemotherapy. The potential adverse interactions included decreased drug bioavailability (apple juice-fexofenadine, atenolol, aliskiren; orange juice-aliskiren, atenolol, celiprolol, montelukast, fluoroquinolones, alendronate; pomelo juice-sildenafil; grape juice-cyclosporine), increased bioavailability (Seville orange juice-felodipine, pomelo juice-cyclosporine, orange-aluminum containing antacids). Unlike furanocoumarin-rich grapefruit juice which could primarily precipitate drug interactions by strong inhibition of cytochrome P450 3A4 isoenzyme and P-glycoprotein and thus cause deadly outcomes due to co-ingestion with some medications, other fruit juices did not precipitate severely detrimental food–drug interaction despite of sporadic case reports. The extent of a juice-drug interaction may be associated with volume of drinking juice, fruit varieties, type of fruit, time between juice drinking and drug intake, genetic polymorphism in the enzymes or transporters and anthropometric variables. Pharmacists and health professionals should properly screen for and educate patients about potential adverse juice-drug interactions and help minimize their occurrence. Much attention should be paid to adolescents and the elderly who ingest medications with drinking fruit juices or consume fresh fruits during drug treatment. Meanwhile, more researches in this interesting issue should be conducted.
format Online
Article
Text
id pubmed-9326888
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93268882022-08-09 Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review Chen, Meng Zhou, Shu-yi Fabriaga, Erlinda Zhang, Pian-hong Zhou, Quan J Food Drug Anal Review Article This review addressed drug interactions precipitated by fruit juices other than grapefruit juice based on randomized controlled trials (RCTs). Literature was identified by searching PubMed, Cochrane Library, Scopus and Web of Science till December 30 2017. Among 46 finally included RCTs, six RCTs simply addressed pharmacodynamic interactions and 33 RCTs studied pharmacokinetic interactions, whereas seven RCTs investigated both pharmacokinetic and pharmacodynamic interactions. Twenty-two juice-drug combinations showed potential clinical relevance. The beneficial combinations included orange juice-ferrous fumarate, lemon juice-(99m)Tc-tetrofosmin, pomegranate juice-intravenous iron during hemodialysis, cranberry juice-triple therapy medications for H. pylori, blueberry juice-etanercept, lime juice-antimalarials, and wheat grass juice-chemotherapy. The potential adverse interactions included decreased drug bioavailability (apple juice-fexofenadine, atenolol, aliskiren; orange juice-aliskiren, atenolol, celiprolol, montelukast, fluoroquinolones, alendronate; pomelo juice-sildenafil; grape juice-cyclosporine), increased bioavailability (Seville orange juice-felodipine, pomelo juice-cyclosporine, orange-aluminum containing antacids). Unlike furanocoumarin-rich grapefruit juice which could primarily precipitate drug interactions by strong inhibition of cytochrome P450 3A4 isoenzyme and P-glycoprotein and thus cause deadly outcomes due to co-ingestion with some medications, other fruit juices did not precipitate severely detrimental food–drug interaction despite of sporadic case reports. The extent of a juice-drug interaction may be associated with volume of drinking juice, fruit varieties, type of fruit, time between juice drinking and drug intake, genetic polymorphism in the enzymes or transporters and anthropometric variables. Pharmacists and health professionals should properly screen for and educate patients about potential adverse juice-drug interactions and help minimize their occurrence. Much attention should be paid to adolescents and the elderly who ingest medications with drinking fruit juices or consume fresh fruits during drug treatment. Meanwhile, more researches in this interesting issue should be conducted. Taiwan Food and Drug Administration 2018-02-15 /pmc/articles/PMC9326888/ /pubmed/29703387 http://dx.doi.org/10.1016/j.jfda.2018.01.009 Text en © 2018 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Review Article
Chen, Meng
Zhou, Shu-yi
Fabriaga, Erlinda
Zhang, Pian-hong
Zhou, Quan
Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title_full Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title_fullStr Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title_full_unstemmed Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title_short Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
title_sort food-drug interactions precipitated by fruit juices other than grapefruit juice: an update review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326888/
https://www.ncbi.nlm.nih.gov/pubmed/29703387
http://dx.doi.org/10.1016/j.jfda.2018.01.009
work_keys_str_mv AT chenmeng fooddruginteractionsprecipitatedbyfruitjuicesotherthangrapefruitjuiceanupdatereview
AT zhoushuyi fooddruginteractionsprecipitatedbyfruitjuicesotherthangrapefruitjuiceanupdatereview
AT fabriagaerlinda fooddruginteractionsprecipitatedbyfruitjuicesotherthangrapefruitjuiceanupdatereview
AT zhangpianhong fooddruginteractionsprecipitatedbyfruitjuicesotherthangrapefruitjuiceanupdatereview
AT zhouquan fooddruginteractionsprecipitatedbyfruitjuicesotherthangrapefruitjuiceanupdatereview